0001209191-22-037535.txt : 20220616 0001209191-22-037535.hdr.sgml : 20220616 20220616173548 ACCESSION NUMBER: 0001209191-22-037535 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220614 FILED AS OF DATE: 20220616 DATE AS OF CHANGE: 20220616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Antal James CENTRAL INDEX KEY: 0001315696 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38436 FILM NUMBER: 221021602 MAIL ADDRESS: STREET 1: 30952 STEEPLECHASE DRIVE CITY: SAN JUAN CAPISTRANO STATE: CA ZIP: 92675 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SIGA TECHNOLOGIES INC CENTRAL INDEX KEY: 0001010086 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133864870 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 31 EAST 62ND STREET CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 212-672-9100 MAIL ADDRESS: STREET 1: 31 EAST 62ND STREET CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: SIGA PHARMACEUTICALS INC DATE OF NAME CHANGE: 19961108 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-14 0 0001010086 SIGA TECHNOLOGIES INC SIGA 0001315696 Antal James C/O SIGA TECHNOLOGIES, INC. 31 EAST 62ND STREET NEW YORK NY 10065 1 0 0 0 Common Stock, par value $.0001 per share 2022-06-14 4 M 0 22831 A 123706 D Common Stock, par value $.0001 per share 2022-06-14 4 D 0 6849 10.26 D 116857 D Restricted Stock Units 2022-06-14 4 M 0 22831 0.00 D Common Stock, par value $.0001 per share 22831 0 D Restricted Stock Units 2022-06-14 4 A 0 14620 0.00 A Common Stock, par value $.0001 per share 14620 14620 D Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis. Reflects RSUs that were cash-settled, per the terms of the compensation program for Board Directors and as noted on the Form 4 filed on June 17, 2021. Partial cash-settlement of RSUs under the Board compensation program is designed to address tax obligations in connection with the vesting of RSUs. The RSUs were granted on June 15, 2021, and fully vested on the date of the Company's 2022 annual meeting of stockholders. RSUs represent contingent rights to receive common stock of the Company on a one-for-one basis, of which up to 4,386 RSUs are expected to settle in cash value thereof but may be settled in shares at the discretion of the board of directors. The RSUs fully vest on the date of the Company's 2023 annual meeting of stockholders. /s/ James Antal 2022-06-15